Viracta Therapeutics News

Viracta Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 27 20:42 ET

Viracta Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

May 26, 2023 18:01 ET

Viracta Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 30, 2021 21:39 ET

Viracta Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 30, 2021 21:36 ET

Viracta Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 30, 2021 21:32 ET

Viracta Therapeutics | EFFECT: Others

Jun 7, 2021 00:15 ET

Viracta Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Feb 16, 2021 16:01 ET

Viracta Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Feb 12, 2021 16:30 ET

Viracta Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Feb 11, 2021 17:14 ET

Viracta Therapeutics | EFFECT: Others

Jan 15, 2021 00:15 ET

Viracta Therapeutics | 424B3: Prospectus

Jan 14, 2021 17:11 ET

Viracta Therapeutics | S-4/A: Registration of securities issued in business combination transactions (Amendment)

Jan 12, 2021 21:54 ET

Viracta Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jan 6, 2021 17:32 ET

Viracta Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Dec 22, 2020 06:26 ET

Viracta Therapeutics | S-4: Registration of securities issued in business combination transactions

Dec 22, 2020 06:24 ET

Viracta Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Dec 7, 2020 06:21 ET

Viracta Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Nov 30, 2020 08:01 ET

Viracta Therapeutics | 424B5: Prospectus

Jul 30, 2020 18:55 ET

Viracta Therapeutics | 424B5: Prospectus

Jul 28, 2020 16:34 ET

Viracta Therapeutics | 424B5: Prospectus

Jul 12, 2019 06:15 ET